Tanya Chotibut

grad student

2010-2014

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Chotibut T, Meadows S, Kasanga EA, et al. (2017) Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model. Movement Disorders : Official Journal of the Movement Disorder Society
Chotibut T, Fields V, Salvatore MF. (2014) Norepinephrine transporter inhibition with desipramine exacerbates L-DOPA-induced dyskinesia: role for synaptic dopamine regulation in denervated nigrostriatal terminals. Molecular Pharmacology. 86: 675-85
Chotibut T, Davis RW, Arnold JC, et al. (2014) Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model. Molecular Neurobiology. 49: 1282-92
Chotibut T, Apple DM, Jefferis R, et al. (2012) Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake. Plos One. 7: e52322
Salvatore MF, Davis RW, Arnold JC, et al. (2012) Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19). Experimental Neurology. 234: 428-36